Decreased expression of the GLP-1 receptor after segmental artery injury in mice.


Journal

The Journal of endocrinology
ISSN: 1479-6805
Titre abrégé: J Endocrinol
Pays: England
ID NLM: 0375363

Informations de publication

Date de publication:
03 2021
Historique:
received: 04 12 2020
accepted: 05 01 2021
pubmed: 16 1 2021
medline: 21 7 2021
entrez: 15 1 2021
Statut: ppublish

Résumé

The glucagon-like peptide-1 receptor (GLP1R) is expressed in the renal vasculature and known to be downregulated under hypertensive conditions in rats and humans. However, little is known about the regulation in other types of renal pathology involving vascular changes. This study investigates the expression of the GLP1R in renal vasculature after glomerular injury in the nephrotoxic nephritis mouse model, high cholesterol, and atherosclerosis in the Ldlr-/- mouse on Western diet, and ex vivo injury in an organ culture model. The immunohistochemical signal of the GLP1R was significantly decreased in arteries from mice with nephrotoxic nephritis after 42 days compared to 7 days and saline control (P < 0.05). Histological evaluation of kidneys from Ldlr-/- mice on Western diet showed a decreased GLP1R specific immunohistochemical signal (P < 0.05). The dilatory response to liraglutide was decreased in Western diet fed Ldlr-/- mice compared to C57Bl/6J controls (P < 0.05). Organ culture significantly decreased the immunohistochemical signal of the GLP1R (P <0.05) and the expression of Glp1r mRNA (P < 0.005) compared to fresh. Organ cultured vessels showed vascular smooth muscle cell remodelling as Acta2 expression was decreased (P < 0.005) and Ednrb was increased (P < 0.05). In conclusion, nephrotoxic nephritis and hypercholesterolaemia led to decreased GLP1R specific immunohistochemical signal. Ex vivo vascular injury in the organ culture model leads to a decrease in expression of GLP1R expressionand contractile VSMC specific markers and increase in expression of dedifferentiation markers suggestive of an inverse relationship between phenotypic switch of the VSMC and the expression of the GLP1R; however, the causal relationship remains elusive.

Identifiants

pubmed: 33449915
doi: 10.1530/JOE-20-0608
pii: JOE-20-0608
doi:
pii:

Substances chimiques

Glp1r protein, mouse 0
Glucagon-Like Peptide-1 Receptor 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

289-301

Auteurs

Katrine Dahl Bjørnholm (KD)

Section of Experimental Animal Models, Department of Veterinary and Animal Sciences, University of Copenhagen, Frederiksberg, Denmark.
Department of Cardiovascular Disease Research, Novo Nordisk, Måløv, Denmark.

Gro Klitgaard Povlsen (GK)

Department of Diabetes Pharmacology 1, Novo Nordisk, Måløv, Denmark.

Maria Elm Ougaard (ME)

Department of Pathology and Imaging, Novo Nordisk, Måløv, Denmark.

Charles Pyke (C)

Department of Pathology and Imaging, Novo Nordisk, Måløv, Denmark.

Günaj Rakipovski (G)

Department of Cardiovascular Disease Research, Novo Nordisk, Måløv, Denmark.

Pernille Tveden-Nyborg (P)

Section of Experimental Animal Models, Department of Veterinary and Animal Sciences, University of Copenhagen, Frederiksberg, Denmark.

Jens Lykkesfeldt (J)

Section of Experimental Animal Models, Department of Veterinary and Animal Sciences, University of Copenhagen, Frederiksberg, Denmark.

Gry Freja Skovsted (GF)

Section of Experimental Animal Models, Department of Veterinary and Animal Sciences, University of Copenhagen, Frederiksberg, Denmark.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH